CLEVELAND, Oct. 6 /PRNewswire/ -- Noveon announced today that it has
purchased certain assets of Thermedics(R) Polymer (Thermedics), a manufacturer
of thermoplastic polyurethane (TPU), from VIASYS Healthcare Inc. This
acquisition will expand Noveon's Estane(R) TPU product lines to the full range
of aliphatic and aromatic TPUs, both of which are used in a variety of
extrusion and injection molding applications.
(Logo: http://www.newscom.com/cgi-bin/prnh/20010523/CLW011LOGO-b )
According to Julian Steinberg, VP and General Manager of Noveon's
Estane(R) TPU product lines, "Combining Thermedics' world-leading aliphatic
TPU technology with Noveon's aromatic TPU organization will accelerate global
growth opportunities and demonstrates Noveon's commitment to continued
leadership in TPU technology."
Thermedics is a leading supplier of custom manufactured thermoplastic
polyurethanes. For two decades, Thermedics has been supplying various
industries with high-performance thermoplastic polyurethanes that were not
readily available from other major TPU suppliers. Thermedics products consist
of medical grade urethanes, optical grade Tecoflex(R), and industrial grade
aliphatic urethanes. The assets being purchased are located in a new
production facility completed in early 2003 in Wilmington, Massachusetts.
Noveon is a leading global producer and marketer of technologically
advanced specialty chemicals for a broad range of consumer and industrial
applications, with revenues in 2002 of $1.1 billion. Noveon is headquartered
in Cleveland, Ohio, with regional centers in Brussels, Belgium, and Hong Kong.
VIASYS Healthcare Inc. is a global, research-based medical technology
company headquartered in Conshohocken, PA.
This release contains forward-looking statements that relate to future
events or performance. These statements reflect the Company's current
expectations, and the Company does not undertake to update or revise these
forward-looking statements, even if experience or future changes make it clear
that any projected results express or implied in this or other Company
statements will not be realized. Furthermore, investors are cautioned that
these statements involve risks and uncertainties, many of which are beyond the
Company's control, which could cause actual results to differ materially from
the forward-looking statements. Further information about these risks can be
found in the Company's filings with the Securities and Exchange Commission.
Investors are cautioned not to place undue reliance on any forward-looking
statements contained herein, which speak only as of the date hereof. The
Company undertakes no obligation to publicly release the result of any
revisions to these forward-looking statements that may be made to reflect
events or circumstances after the date hereof or to reflect the occurrence of
unanticipated events.
SOURCE Noveon, Inc.
 back to top
Related links:
http://www.noveoninc.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20010523/CLW011LOGO-b
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, 888-776-6555 or 212-782-2840
Company News On-Call:
http://www.prnewswire.com/comp/156774.html
CONTACT:
Sean Stack of Noveon, Inc., +1-216-447-6494
|
